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Introduction
In critical illness, the rapid depletion of glutamine has
been associated with increased mortality [1]. This has
led to the concept that early glutamine suppletion
would benefit these patients.
A recent trial [2] however showed that early supple-
tion of glutamine was associated with an increased mor-
tality. In a majority of patients glutamine levels were
within normal range at admission. Patients with severe
traumatic brain injury (TBI) and subarachnoid haemor-
rhage (SAH) however, were excluded in this trial. In lit-
erature no data on glutamine levels are available in
critically ill neurologic patients.
Objectives
We conducted an observational pilot study measuring
glutamine levels in the first week after TBI and acute
SAH.
Methods
In a 30-bed intensive care unit of a teaching hospital
patients admitted with TBI (n=5) and SAH (n=5) were
selected. Plasma glutamine levels were measured at
admission and on six consecutive days. Glutamine defi-
ciency was defined as a plasma glutamine level of less
than 420 µmol/L. Optimal nutrition per patient was cal-
culated by a dietician. Jevity® standard, Plus and HiCal
(Abbott Nutrition) were used containing 0.36-0.40 gram
glutamine/100 kcal. Actual intake was noted in a Patient
Data Management System (Metavision®, iMDsoft). Data




Mean glutamine level in TBI and SAH patients was
334.8 ± 83.7 µmol/L and 446.8 ± 97.4 µmol/L at admis-
sion. Glutamine deficiency was common: 7 out of 10
patients were deficient according to the definition
(Table 1.) Optimal intake per individual was calculated
to be 2022 ± 498 kcal/120 ± 36 grams of protein. Due
to several causes i.e. gastric retention and passage disor-
ders, actual intake was 1480 ± 580 kcal and 77 ± 35
grams of protein, primarily via nasogastric tube feeding.
This was 72% and 71% of calculated optimal calorie and
protein intake. After seven days of treatment and nutri-
tional support glutamine levels increased significantly in
all patients with TBI (451 ± 146.5 µmol/L) and SAH
(476 ± 84.2 µmol/L). In one SAH patient glutamine
level declined but remained in normal range (Figure 1.).
Conclusions
We found low glutamine levels in 70% of TBI and SAH
patients at admission but no evidence of glutamine
depletion during treatment. Intake of only 72% of
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Age (median, years) 60 54
Gender (male/female, %) 29/71 67/33
Type of patient (SAH/TBI,
%)
43/57 67/33








3-Month mortality (%) 57 0
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calculated optimal calorie intake and 71% of protein
intake was sufficient to reach near-normal levels of glu-
tamine in patients with TBI and SAH.
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